Nampoothiri Ram V, Duseja Ajay, Rathi Manish, Agrawal Swastik, Sachdeva Naresh, Mehta Manu, Dhaliwal Harpal S, Dhiman Radha K, Chawla Yogesh
Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
J Clin Exp Hepatol. 2019 Jan-Feb;9(1):22-28. doi: 10.1016/j.jceh.2017.12.005. Epub 2017 Dec 30.
There is sparse data on the prevalence of renal dysfunction in patients with nonalcoholic fatty liver disease (NAFLD). The aim of the present study was to evaluate the presence of renal dysfunction in patients with NAFLD and correlate it with the severity of liver disease.
One hundred nonalcoholic patients with ultrasound showing hepatic steatosis were enrolled into the study after exclusion of other causes. Presence of renal dysfunction was estimated by glomerular filtration rate and by evaluating 24 h urinary protein and microalbumin. Various risk factors including components of metabolic syndrome, severity of hepatic steatosis (as assessed on ultrasound), hepatic necro-inflammation (as assessed by hepatic transaminases) and hepatic fibrosis (as assessed by transient elastography) were correlated with the presence of renal dysfunction.
Twenty eight (28%) patients with NAFLD had evidence of impaired renal function with 5 (5%) having abnormal glomerular filtration rate, 18 (18%) having significant proteinuria and 5 (5%) having both. Presence of type 2 diabetes mellitus, raised hepatic transaminases and advanced fibrosis on transient elastography were found as independent predictors of impaired renal function with raised hepatic transaminases having the best sensitivity (89%) and presence of advanced fibrosis the best specificity (90%). A model comprising of these three parameters had good accuracy (AUROC = 0.763) in predicting impaired renal function in patients with NAFLD.
Around one-third of patients with NAFLD have impaired renal functions. Prevalence of impaired renal function in patients with NAFLD is dependent on the severity of liver disease and presence of diabetes mellitus.
关于非酒精性脂肪性肝病(NAFLD)患者肾功能不全患病率的数据稀少。本研究的目的是评估NAFLD患者肾功能不全的存在情况,并将其与肝病严重程度相关联。
排除其他病因后,纳入100例超声显示肝脂肪变性的非酒精性患者。通过肾小球滤过率以及评估24小时尿蛋白和微量白蛋白来估计肾功能不全的存在情况。将各种危险因素,包括代谢综合征的组成成分、肝脂肪变性的严重程度(通过超声评估)、肝坏死性炎症(通过肝转氨酶评估)和肝纤维化(通过瞬时弹性成像评估)与肾功能不全的存在情况相关联。
28例(28%)NAFLD患者有肾功能受损的证据,其中5例(5%)肾小球滤过率异常,18例(18%)有显著蛋白尿,5例(5%)两者皆有。2型糖尿病的存在、肝转氨酶升高和瞬时弹性成像显示的进展性纤维化被发现是肾功能受损的独立预测因素,其中肝转氨酶升高具有最佳敏感性(89%),进展性纤维化的存在具有最佳特异性(90%)。由这三个参数组成的模型在预测NAFLD患者肾功能受损方面具有良好的准确性(受试者工作特征曲线下面积=0.763)。
约三分之一的NAFLD患者存在肾功能受损。NAFLD患者肾功能受损的患病率取决于肝病的严重程度和糖尿病的存在情况。